Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | CSF1R | P07333 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23074699 | 1.00 | ALDH1A1 (0.43) | ALDH1A1POLBTSHRMAPK1LTA4H | |
| SCHEMBL23074710 | 0.84 | HRH4 (0.41) | LTA4HCYP3A4CYP2D6CYP1A2CYP2C9 | |
| SCHEMBL23074671 | 0.83 | ALDH1A1 (0.53) | ALDH1A1LTA4H | |
| SCHEMBL23074716 | 0.82 | CHRNB2 (0.58) | CHRNB2CHRNA4 | |
| SCHEMBL23074644 | 0.81 | KDM4E (0.51) | ALDH1A1CYP2D6CYP1A2CYP2C19NFE2L2 | |
| SCHEMBL23074697 | 0.81 | HTR2A (0.47) | ALDH1A1LTA4HNFE2L2 | |
| SCHEMBL23074674 | 0.78 | HRH3 (0.47) | ALDH1A1TSHRLTA4HCYP2D6CYP1A2 | |
| SCHEMBL23074692 | 0.77 | KMT2A (0.48) | ALDH1A1TSHRLTA4HNFE2L2 | |
| SCHEMBL23074677 | 0.77 | HRH3 (0.50) | ALDH1A1CYP2D6CYP1A2CYP2C19NFE2L2 | |
| SCHEMBL13406717 | 0.75 | ALDH1A1 (0.49) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210069692-A1 | ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS | BIO-RAD LABORATORIES, INC. | 2021-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210069692-A1 | ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS | ABCG2, SLC7A1, MSR1 | ALDH1A1 4738/4885POLB 4293/4885TSHR 1626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.